Similar articles

• Brain pyruvate kinase activity in PKU model systems.

  Akeson AL, Berry HK, Brunner RL, Vorhees CV. Akeson AL, et al. J Neurochem. 1979 Jan;32(1):233-5. doi: 10.1111/j.1471-4159.1979.tb04534.x. J Neurochem. 1979. PMID: 153382 No abstract available.
• Maternal hyperphenylalaninaemia in the normal and phenylketonuric mother and its influence on maternal plasma and fetal fluid amino acid concentrations.

  Cockburn F, Farquhar JW, Forfar JO, Giles M, Robins SP. Cockburn F, et al. J Obstet Gynaecol Br Commonw. 1972 Aug;79(8):698-707. doi: 10.1111/j.1471-0528.1972.tb12903.x. J Obstet Gynaecol Br Commonw. 1972. PMID: 5070883 No abstract available.
• Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets.

  van Spronsen FJ, van Rijn M, Bekhof J, Koch R, Smit PG. van Spronsen FJ, et al. Am J Clin Nutr. 2001 Feb;73(2):153-7. doi: 10.1093/ajcn/73.2.153. Am J Clin Nutr. 2001. PMID: 11157309 Review.
• Inhibition of human brain pyruvate kinase and hexokinase by phenylalanine and phenylpyruvate: possible relevance to phenylketonuric brain damage.

  Weber G. Weber G. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1365-9. doi: 10.1073/pnas.63.4.1365. Proc Natl Acad Sci U S A. 1969. PMID: 5260939 Free PMC article.
• Development of enzyme systems.

  Hahn P, Skala J. Hahn P, et al. Clin Obstet Gynecol. 1971 Sep;14(3):655-68. doi: 10.1097/00003081-197109000-00002. Clin Obstet Gynecol. 1971. PMID: 4400781 Review. No abstract available.